The changes include recommendations for first line immunotherapy in patients with high PD-L1 expression, and clarification on use of targeted therapies.
With sequence data for hundreds of advanced breast cancer samples, investigators identified genetic alterations shared with — and distinct from — those in primary tumors.
A Complete Genomics-led team isolated and sequenced the genomes of 34 circulating tumor cells from a woman with metastatic breast cancer.
The ThromboSeq test detected early-stage cancer with 81 percent accuracy and late-stage cancer with 88 percent accuracy.
Hospital will partner with several other institutions in this effort to support data-driven research into pediatric cancers and structural birth defects.
The study, launched today, aims to evaluate the use of liquid biopsy and natural killer cell testing for the early detection of recurrent breast cancer.
Using data from TCGA and the HPA, they looked at the prognostic role of each protein-coding gene in 7,932 tumor samples spanning 17 different tumor types.
Investigators will use Biocept's liquid biopsy tests to detect ALK rearrangements both at baseline and to monitor treatment response and resistance mechanisms.
The agricultural company said it will use the licensed technology to develop improved and sustainable crops.
The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.
In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.
Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.
A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.